
News|Articles|May 18, 2016
Well Care Compounding Pharmacy Issues Recall
Author(s)Pharmaceutical Technology Editors
The company recalls products due to sterility concerns.
Advertisement
FDA announced on May 17, 2016 that Well Care Compounding Pharmacy (Las Vegas, NV) is voluntarily recalling sterile compounded products distributed between Jan. 1–April 29, 2016. The recall comes after an FDA inspection of the facility that resulted in sterility assurance concerns.
The company states in a
Source:
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
What Does TAUKLARIFY's Approval Mean for Alzheimer's Drug Developers?
2
PharmTech Weekly Roundup—August 14, 2026
3
Q&A: Why Is Halo Pharma Expanding Into Sterile Injectables Now?
4
Europe Tried to Ban Generative AI From Critical GMP. The Ban May Not Survive. It Does Not Matter.
5




